215 related articles for article (PubMed ID: 22864944)
21. Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
Hesselink MB; Smolders H; De Boer AG; Breimer DD; Danysz W
Behav Pharmacol; 1999 Feb; 10(1):85-98. PubMed ID: 10780305
[TBL] [Abstract][Full Text] [Related]
22. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
23. Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice.
Malec D; Mandryk M; Fidecka S
Pharmacol Rep; 2008; 60(2):149-55. PubMed ID: 18443375
[TBL] [Abstract][Full Text] [Related]
24. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats.
Wegert S; Ossipov MH; Nichols ML; Bian D; Vanderah TW; Malan TP; Porreca F
Pain; 1997 May; 71(1):57-64. PubMed ID: 9200174
[TBL] [Abstract][Full Text] [Related]
25. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.
Fischer BD; Ward SJ; Henry FE; Dykstra LA
Neuropharmacology; 2010 Feb; 58(2):544-50. PubMed ID: 19699755
[TBL] [Abstract][Full Text] [Related]
27. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain.
Mao J; Price DD; Mayer DJ
Pain; 1995 Jun; 61(3):353-364. PubMed ID: 7478678
[TBL] [Abstract][Full Text] [Related]
28. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
Medvedev IO; Dravolina OA; Bespalov AY
J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
[TBL] [Abstract][Full Text] [Related]
29. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
Le Guen S; Catheline G; Besson JM
Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
[TBL] [Abstract][Full Text] [Related]
30. Working memory in the odor span task: effects of chlordiazepoxide, dizocilpine (MK801), morphine, and scopolamine.
Galizio M; Deal M; Hawkey A; April B
Psychopharmacology (Berl); 2013 Jan; 225(2):397-406. PubMed ID: 22918519
[TBL] [Abstract][Full Text] [Related]
31. N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4- isoxazoleproprionate (AMPA) glutamate-receptor antagonists have different interactions with the discriminative stimuli of abused drugs.
Jackson A; Brown G; Stephens DN
Psychopharmacology (Berl); 1996 Dec; 128(3):320-7. PubMed ID: 8972552
[TBL] [Abstract][Full Text] [Related]
32. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; RodrÃguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
33. Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats.
Bespalov AY; Beardsley PM; Balster RL
Pharmacol Biochem Behav; 1998 Jun; 60(2):507-17. PubMed ID: 9632234
[TBL] [Abstract][Full Text] [Related]
34. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
Witkin JM; Steele TD; Sharpe LG
J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
[TBL] [Abstract][Full Text] [Related]
35. Neurophysiological response properties of medullary pain-control neurons following chronic treatment with morphine or oxycodone: modulation by acute ketamine.
Viisanen H; Lilius TO; Sagalajev B; Rauhala P; Kalso E; Pertovaara A
J Neurophysiol; 2020 Sep; 124(3):790-801. PubMed ID: 32755331
[TBL] [Abstract][Full Text] [Related]
36. The N-Methyl-D-aspartate receptor antagonist dizocilpine inhibits associative antinociceptive tolerance to morphine in mice: relation with memory.
Nakama-Kitamura M
J Pharmacol Sci; 2005 Jan; 97(1):75-82. PubMed ID: 15644592
[TBL] [Abstract][Full Text] [Related]
37. A novel role of spinal astrocytic connexin 43: mediating morphine antinociceptive tolerance by activation of NMDA receptors and inhibition of glutamate transporter-1 in rats.
Shen N; Mo LQ; Hu F; Chen PX; Guo RX; Feng JQ
CNS Neurosci Ther; 2014 Aug; 20(8):728-36. PubMed ID: 24629168
[TBL] [Abstract][Full Text] [Related]
38. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
39. Effects of memantine on estrogen-dependent acute tolerance to the morphine analgesia in female rats.
Shekunova EV; Bespalov AY
Eur J Pharmacol; 2006 Mar; 535(1-3):78-85. PubMed ID: 16546163
[TBL] [Abstract][Full Text] [Related]
40. Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.
Paronis CA; Holtzman SG
Psychopharmacology (Berl); 1994 May; 114(4):601-10. PubMed ID: 7855222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]